Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	3.45B
Revenue (ttm)	2.83B -2.0%
Net Income	136.68M
EPS	4.17
Shares Out	34.34M
PE Ratio	24.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,986
Average Volume	46,107
Open	100.10
Previous Close	99.50
Day's Range	99.00 - 102.01
52-Week Range	97.75 - 154.40
Beta	n/a
RSI	42.79
Earnings Date	Feb 10, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2025, Amanta Healthcare's revenue was 2.75 billion, a decrease of -2.01% compared to the previous year's 2.80 billion. Earnings were 105.01 million, an increase of 189.02%.